News | Stroke | April 06, 2017

San Clemente Physician Successfully Treats Stroke Patients With Hyperbaric Oxygen

Treatment activates neuroplasticity and improves stroke-induced neurologic deficiencies

hyperbaric oxygen treatment, HBOT, stroke, David Steenblock D.O.

Image courtesy of David Steenblock, D.O.


April 6, 2017 — David Steenblock, D.O., an osteopathic physician based in San Clemente, Calif., recently discussed his use of hyperbaric oxygen to achieve significant and improved lifestyle outcomes for many stroke patients. The technique involves the therapeutic use of oxygen under pressure to dramatically reduce the effects of stroke and brain injury.

“Many of our cases have demonstrated a 40-100 percent rate of improvement for stroke victims who received oxygen under pressure, “ said Steenblock. He encourages U.S. physicians to consider the merits of this approach.

Steenblock treated a 62-year old patient with a stroke that completely paralyzed her right arm and left her severally bent over and limping, He prescribed his patient a series of 60 treatments within 12 weeks in a hyperbaric oxygen chamber. Increasing a person’s level of dissolved oxygen using HBOT can activate neuroplasticity and improve stroke-induced neurologic deficiencies, he added.

The goal is to get as much oxygen into the brain as possible. This helps to revive oxygen-starved, damaged brain tissue, Steenblock explained. This principle holds true for traumatic brain injury as well, where brain tissue is irreversibly destroyed, as brain cells deprived of oxygen usually die within 10 minutes, but a larger portion is potentially revivable.

After one month of treatment, the patient showed clear signs of improvement, with walking, posture and range of motion noticeably improved. She was able to open and close her right hand, grip and squeeze objects, and raise her arm to her chest.

For more information: www.stemcellmd.org


Related Content

News | Stroke

March 10, 2026 — Medtronic has entered into a definitive agreement to acquire Scientia Vascular, a company with critical ...

Home March 12, 2026
Home
News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Home March 11, 2026
Home
News | Stroke

Feb. 6, 2026 — Rapid Medical, a developer of active endovascular devices, has announced the latest results from the ...

Home February 10, 2026
Home
News | Stroke

Feb. 2, 2026 — Brainomix, a provider of AI-powered imaging tools in stroke and lung fibrosis, is introducing its new ...

Home February 02, 2026
Home
News | Stroke

Jan. 13, 2026 — A streamlined, nurse-led response for hospitalized patients experiencing an acute stroke at a Texas ...

Home January 15, 2026
Home
News | Stroke

Dec. 3, 2025 — Recross Cardio Inc., a structural heart company developing next-generation membrane sealing technology ...

Home December 04, 2025
Home
News | Stroke

Dec. 2, 2025 — Brainomix, a provider of AI-powered imaging tools in stroke and lung fibrosis, has announced the ...

Home December 03, 2025
Home
News | Stroke

Nov. 10, 2025 — Sentante, a med-tech robotics company, has successfully demonstrated a first-of-a-kind remote stroke ...

Home November 10, 2025
Home
News | Stroke

Oct. 22, 2025 — Basking Biosciences, a clinical-stage biopharmaceutical company developing the first reversible ...

Home October 22, 2025
Home
News | Stroke

Oct. 21, 2025 — At the seventeenth edition of the World Stroke Congress in Barcelona, Siemens Healthineers will present ...

Home October 21, 2025
Home
Subscribe Now